James Raders, MD
Urogynecology and Reconstructive Pelvic Surgery · Melbourne, FLNPI 1548278245
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 81.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $8,153, more than ten times the $48 reported in 2019.
Across 79 payments — averaging $129.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$8K
- Femselect Inc.$1K
- Boston Scientific$339
- Intuitive Surgical$87
- AbbVie$62
- Astellas Pharma US Inc$61
- plus $58 from 3 others
Across 1 payment — averaging $472.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$473
What the payments were for
- Speaking & faculty fees$3,60035%
- Travel & lodging$2,27622%
- Food & beverage$4,33842%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 60 | $8,340 |
| Femselect Inc. | 4 | $1,266 |
| Boston Scientific | 4 | $339 |
| Intuitive Surgical | 1 | $87 |
| AbbVie(2 entities) | 3 | $62 |
| Astellas Pharma US Inc | 4 | $61 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Axonics, Inc. | 1 | $21 |
| Coloplast | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,214 in reported general payments places this provider in the 70th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
See all urogynecology and reconstructive pelvic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 161 | $142,962 |
| MyrbetriqMirabegron | 131 | $122,013 |
| Mirabegron ErMirabegron | 18 | $12,907 |
| Estradiol | 188 | $11,242 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 81 | $823 |
| Clobetasol Propionate | 13 | $327 |
| Fluconazole | 14 | $179 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 31 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $61 | $122,013131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
Other urogynecology and reconstructive pelvic surgery in Melbourne
- Aimee TieuMelbourne$5K
- Nathan KowOrlando$116K
- Amir ShariatiCoconut Creek$106K
- Charbel SalamonOrlando$100K
- Allison WymanTampa$69K
- Nicole SzellLargo$54K
- Jose Lazaro WeissOviedo$28K
- Paul PettitJacksonville$27K
- Arash RahiCoconut Creek$23K
- Moises VirellesWellington$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.